Indoco Remedies Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Indoco Remedies Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Indoco Remedies Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news and updates on Indoco Remedies Ltd. from all sources in a single place.

Load latest

Indoco Remedies Ltd.

04 Jun 2023

247.05

-0.43%

Company Update

INDOCO REMEDIES LTD. - 532612 - Indoco Remedies Limited Clinical Research Organisation (CRO), Anacipher, Receives Clearance …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Company's Clinical Research Organisation, AnaCipher, located in Hyderabad, was inspected by the United States Food and Drug Administration (USFDA) in July 2022. The USFDA has confirmed that no objectionable conditions were observed during their remote assessment. You are requested to kindly take the same on record

pdf

Indoco Remedies Ltd.

03 Jun 2023

247.05

-0.43%

Company Update

INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that United States Food and Drug Administration (USFDA) had inspected Company's Sterile Facility (Plant II) located at Goa('Facility'), from February 20, 2023 to February 28, 2023. The said Facility had 4 observations in Form 483. USFDA has determined the inspection classification of this Facility as OAI (Official Action Indicated). The Company is committed towards working with USFDA for remediation of the concerns on highest priority.

pdf

Indoco Remedies Ltd.

30 May 2023

247.05

-0.43%

Company Update

INDOCO REMEDIES LTD. - 532612 - Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory …

BSE India

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith a copy of the letter along with necessary forms dispatched to the shareholders holding shares in physical mode, in compliance with the SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated 16th March, 2023.

pdf

Indoco Remedies Ltd.

27 May 2023, 01:22PM

247.05

-0.43%

Company Update

INDOCO REMEDIES LTD. - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to Regulation 24A(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Secretarial Compliance Report dated 25th May, 2023 for the Financial Year 2022-23 issued by our secretarial auditor CS Ajit Sathe, Proprietor of M/s. A. Y. Sathe & Co., Company Secretaries. We request you to kindly take the above in your records.

pdf

Indoco Remedies Ltd.

27 May 2023, 12:04PM

247.05

-0.43%

Company Update

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Newspaper advertisement confirming dispatch of the Postal Ballot Notice published on 27th May, 2023 in Business Standard (English) (All Editions), and Mumbai Lakshdeep (Marathi). We request you to kindly take the above in your records.

pdf

Indoco Remedies Ltd.

26 May 2023, 04:36PM

247.05

-0.43%

Buy Indoco Remedies; target of Rs 400: Prabhudas Lilladher

Moneycontrol

Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 400 in its research report dated May 24, 2023.

Indoco Remedies Ltd. average weekly volume is high.

Indoco Remedies Ltd.

26 May 2023, 03:37PM

247.05

-0.43%

Earnings Call

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed the transcript of Earnings Conference Call held on 23rd May, 2023 in respect of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2023.

pdf

Indoco Remedies Ltd.

26 May 2023, 02:50PM

247.05

-0.43%

AGM

INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed copy of the postal ballot notice dated 23rd May, 2023 ('Postal Ballot Notice') to seek approval of the shareholders for re-appointment of Mr. Suresh G. Kare as Chairman of the Company in the capacity of Non-Executive Non Independent Director and to advance any loan, give any guarantee or to provide any security to all such person specified under section 185 of the Companies Act, 2013.

pdf